The HeartAssist5® Ventricular Assist Device (VAD) precisely measures a patient’s True Flow (blood flow through the device) in real time, and this data is uploaded to VADLink.com provided by Numerex, the world’s leading provider of Machine to Machine (M2M) communications for the Internet of Things IoT.
True Flow via VADLink.com can be monitored by a patient’s clinician 24/7, and if there is any drop in flow below a minimum threshold, the clinician can be notified immediately. Early warning and intervention is a key to improving LVAD patient outcomes.
The upgrade by Numerex to be completed in 2015, adds more patient data to the VADLink clinical dashboard, including INR readings, blood pressure and weight.
Please read M2M Connectivity Plays Important Role for Patients Awaiting Heart Transplant Worldwide for more about how the Numerex Network securely connects HeartAssist5® patients to their clinicians.
ReliantHeart, Inc. is an innovative supplier of advanced mechanical circulatory assist technologies that are changing the approach to the treatment of advanced heart failure. It develops and manufactures the HeartAssist5® Ventricular Assist Device. ReliantHeart’s roots are in Houston, Texas, where it has been generously influenced by the transplant centers of Texas Heart, Methodist DeBakey and Memorial Hermann, and its technology originally inspired by NASA, the Johnson Space Center and Baylor School of Medicine.
Numerex Corp. is a leading provider of interactive and on-demand machine-to-machine (M2M) enterprise solutions enabling the Internet of Things (IoT). The Company’s solutions produce new revenue streams or create operating efficiencies for its customers. Numerex provides its technology and services through its integrated M2M horizontal platforms, which are generally sold on a subscription basis. Numerex is ISO 27001 information security-certified, highlighting the Company’s focus on M2M data security, service reliability and around-the-clock support of its customers’ M2M solutions.